Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.
HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Update of the Drug Resistance Mutations in HIV-1.
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.
The effect of oxidative environment on immunosuppressive properties of human seminal plasma.
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.